"Designer Drugs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.
| Descriptor ID |
D015198
|
| MeSH Number(s) |
D26.200
|
| Concept/Terms |
Designer Drugs- Designer Drugs
- Drugs, Designer
- Customized Drugs
- Drugs, Customized
|
Below are MeSH descriptors whose meaning is more general than "Designer Drugs".
Below are MeSH descriptors whose meaning is more specific than "Designer Drugs".
This graph shows the total number of publications written about "Designer Drugs" by people in this website by year, and whether "Designer Drugs" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2017 | 2 | 2 | 4 |
| 2018 | 2 | 2 | 4 |
| 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Designer Drugs" by people in Profiles.
-
A Liquid-Chromatography High-Resolution Mass Spectrometry Method for Non-FDA Approved Benzodiazepines. J Anal Toxicol. 2019 May 01; 43(4):316-320.
-
Simultaneous Determination of Amphetamine-Related New Psychoactive Substances in Urine by Gas Chromatography-Mass Spectrometry. J Anal Toxicol. 2018 Nov 01; 42(9):605-616.
-
Hemorrhagic Highs from Synthetic Cannabinoids - A New Epidemic. N Engl J Med. 2018 09 27; 379(13):1275-1277.
-
["Addictive substances": A new thematic series]. Rev Mal Respir. 2018 06; 35(6):589-591.
-
Activation of the Medial Prefrontal Cortex Reverses Cognitive and Respiratory Symptoms in a Mouse Model of Rett Syndrome. eNeuro. 2017 Nov-Dec; 4(6).
-
Activation of endogenous arginine vasopressin neurons inhibit food intake: by using a novel transgenic rat line with DREADDs system. Sci Rep. 2017 Nov 16; 7(1):15728.
-
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review. Neuropharmacology. 2018 05 15; 134(Pt A):121-132.
-
Down-regulation of cholinergic signaling in the habenula induces anhedonia-like behavior. Sci Rep. 2017 04 18; 7(1):900.
-
Designer drugs: Review and implications for emergency management. Hum Exp Toxicol. 2018 Jan; 37(1):94-101.
-
Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis. Clin Toxicol (Phila). 2012 Dec; 50(10):1165-8.